2-PMDQCAS# 139047-55-5 |
- ABT-751 (E7010)
Catalog No.:BCC1085
CAS No.:141430-65-1
- CHM 1
Catalog No.:BCC2387
CAS No.:154554-41-3
- Podophyllotoxin
Catalog No.:BCN5957
CAS No.:518-28-5
- D-64131
Catalog No.:BCC1510
CAS No.:74588-78-6
- CYT997 (Lexibulin)
Catalog No.:BCC4601
CAS No.:917111-44-5
- MPC 6827 hydrochloride
Catalog No.:BCC8040
CAS No.:917369-31-4
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 139047-55-5 | SDF | Download SDF |
| PubChem ID | 6081682 | Appearance | Powder |
| Formula | C21H23N5O | M.Wt | 361.45 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble to 10 mM in DMSO and in ethanol | ||
| Chemical Name | 2-[(4-phenylpiperazin-1-yl)methyl]-3,6-dihydro-2H-imidazo[1,2-c]quinazolin-5-one | ||
| SMILES | C1CN(CCN1CC2CN3C(=N2)C4=CC=CC=C4NC3=O)C5=CC=CC=C5 | ||
| Standard InChIKey | ONSOQRPYFKDOEB-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C21H23N5O/c27-21-23-19-9-5-4-8-18(19)20-22-16(15-26(20)21)14-24-10-12-25(13-11-24)17-6-2-1-3-7-17/h1-9,16H,10-15H2,(H,23,27) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Potent and selective α1-adrenoceptor antagonist and antihypertensive. |
2-PMDQ Dilution Calculator
2-PMDQ Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.7666 mL | 13.8332 mL | 27.6663 mL | 55.3327 mL | 69.1659 mL |
| 5 mM | 0.5533 mL | 2.7666 mL | 5.5333 mL | 11.0665 mL | 13.8332 mL |
| 10 mM | 0.2767 mL | 1.3833 mL | 2.7666 mL | 5.5333 mL | 6.9166 mL |
| 50 mM | 0.0553 mL | 0.2767 mL | 0.5533 mL | 1.1067 mL | 1.3833 mL |
| 100 mM | 0.0277 mL | 0.1383 mL | 0.2767 mL | 0.5533 mL | 0.6917 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- JMV 449
Catalog No.:BCC5863
CAS No.:139026-66-7
- Oplodiol
Catalog No.:BCN6204
CAS No.:13902-62-0
- Catalpin
Catalog No.:BCN6205
CAS No.:1390-72-3
- Carmine
Catalog No.:BCN2223
CAS No.:1390-65-4
- 3,4-Dihydroxybenzaldehyde
Catalog No.:BCN6214
CAS No.:139-85-5
- Ziprasidone hydrochloride monohydrate
Catalog No.:BCC2072
CAS No.:138982-67-9
- Capsazepine
Catalog No.:BCC1451
CAS No.:138977-28-3
- Coronarin D ethyl ether
Catalog No.:BCN6203
CAS No.:138965-89-6
- Isocoronarin D
Catalog No.:BCN6202
CAS No.:138965-88-5
- Rutaretin
Catalog No.:BCN4710
CAS No.:13895-92-6
- Ibandronate sodium
Catalog No.:BCC4665
CAS No.:138926-19-9
- Entadamide-A-β-D-glucopyranoside
Catalog No.:BCN8452
CAS No.:138916-58-2
- Anemarsaponin B
Catalog No.:BCN6289
CAS No.:139051-27-7
- L-689,560
Catalog No.:BCC6774
CAS No.:139051-78-8
- PF-4981517
Catalog No.:BCC2270
CAS No.:1390637-82-7
- (-)-Heraclenol
Catalog No.:BCN7682
CAS No.:139079-42-8
- Tristin
Catalog No.:BCN4709
CAS No.:139101-67-0
- PF 4800567 hydrochloride
Catalog No.:BCC7904
CAS No.:1391052-28-0
- Vigabatrin Hydrochloride
Catalog No.:BCC5198
CAS No.:1391054-02-6
- Zanamivir
Catalog No.:BCC4946
CAS No.:139110-80-8
- BM-1074
Catalog No.:BCC2235
CAS No.:1391108-10-3
- Isomurralonginol acetate
Catalog No.:BCN4708
CAS No.:139115-59-6
- Tripterifordin
Catalog No.:BCN6206
CAS No.:139122-81-9
- Uralenol
Catalog No.:BCN7994
CAS No.:139163-15-8
Studies on quinazolines. 5. 2,3-dihydroimidazo[1,2-c]quinazoline derivatives: a novel class of potent and selective alpha 1-adrenoceptor antagonists and antihypertensive agents.[Pubmed:8101878]
J Med Chem. 1993 Jul 23;36(15):2196-207.
A series of 2-[(substituted phenylpiperazin-1-yl)methyl]- and 2-[(substituted phenylpiperidin-1-yl)methyl]-2,3-dihydroimidazo[1,2- c]quinazolin-5(6H)-ones or -5(6H)-thiones, and 3-[(substituted phenylpiperazin-1-yl)methyl]-2,3-dihydroimidazo[1,2-c]quinaz oline derivatives were synthesized, as conformationally restricted analogues of SGB-1534 and ketanserin, for evaluation as alpha-antagonists and antihypertensive agents. Most compounds containing a (substituted phenylipiperazinyl)methyl side chain displayed high binding affinity for alpha 1-adrenoceptor with no significant activity at alpha 2-sites. Compounds having a (substituted phenylpiperazinyl)methyl at the 3-position of 2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one ring system had a better activity than those with the same substituent at the 2-position. Structure-activity relationships for alpha 1-adrenoceptor affinity are presented and indicate that compounds with substitution at the ortho position on the benzene ring of the phenylpiperazine side chain moiety are more potent than those without substitution and/or substitutions at the 3- and 4-positions. Computer-assisted superimposition of SGB-1534 and 20b showed little structural correspondence between the quinazolinone and 2,3-dihydroimidazo[1,2-c]quinazoline nucleus, and specific interactions of these molecular fragments with the receptor protein appear unlikely. Antihypertensive activity was evaluated via intravenous administration of each compound to spontaneously hypertensive rats, and compounds (16a, 16b, 20b, and 28b) illustrated similar efficacy to SGB-1534 when assessed after 6 h. The pA2 value for 16a against phenylephedrine in rat aorta was much higher than that of prazosin. On the basis of alpha 1-adrenoceptor affinity/selectivity in vitro and duration of antihypertensive action in vivo, compounds 20b and 28b warrant further evaluation.
